MARKET

STRO

STRO

Sutro Biopharma
NASDAQ
15.52
+0.92
+6.30%
After Hours: 15.00 -0.52 -3.35% 17:44 02/06 EST
OPEN
14.85
PREV CLOSE
14.60
HIGH
16.24
LOW
14.27
VOLUME
108.98K
TURNOVER
--
52 WEEK HIGH
21.25
52 WEEK LOW
5.23
MARKET CAP
132.22M
P/E (TTM)
-0.5974
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at STRO last week (0126-0130)?
Weekly Report · 5d ago
Sutro Biopharma (STRO) Gets a Sell from Bank of America Securities
TipRanks · 01/27 13:27
Weekly Report: what happened at STRO last week (0119-0123)?
Weekly Report · 01/26 09:22
Sutro Biopharma Price Target Announced at $23.00/Share by Citizens
Dow Jones · 01/20 10:34
Sutro Biopharma Raised to Market Outperform From Market Perform by Citizens
Dow Jones · 01/20 10:34
Citizens Upgrades Sutro Biopharma to Market Outperform, Announces $23 Price Target
Benzinga · 01/20 10:25
Sutro Biopharma upgraded to Outperform from Market Perform at Citizens
TipRanks · 01/20 09:45
Weekly Report: what happened at STRO last week (0112-0116)?
Weekly Report · 01/19 09:24
More
About STRO
Sutro Biopharma, Inc. is an oncology company engaged in developing site-specific and novel-format antibody drug conjugates (ADCs), enabled by its proprietary integrated cell-free protein synthesis platform, XpressCF, and its site-specific conjugation platform, XpressCF+. It designs and develops therapeutics using the relevant and potent modalities, including ADCs, bispecific ADCs, immunostimulatory ADCs, and dual conjugate ADCs. Enabled through its XpressCF and XpressCF+ platforms, it has entered multi-target, product-focused collaborations with pharmaceutical and biotechnology companies in the field of oncology, with its ongoing relationships that include licensing to Ipsen, on an exclusive basis, the right to research, develop, manufacture and commercialize STRO-003. STRO-003 is developed for the treatment of solid tumors. Its XpressCF and XpressCF platforms supports Vaxcyte, focused on discovery and development of vaccines for the treatment and prophylaxis of infectious disease.

Webull offers Sutro Biopharma Inc stock information, including NASDAQ: STRO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, STRO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading STRO stock methods without spending real money on the virtual paper trading platform.